Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications

Mol Cell Biochem. 2016 Oct;421(1-2):103-10. doi: 10.1007/s11010-016-2790-2. Epub 2016 Aug 24.

Abstract

This study evaluated the association of NOS3 polymorphisms with hypertension risk and complications. eNOS (G894T) SNP was performed by RT-PCR on 70 hypertensive patients (25 were hypertensive, 25 were hypertensive with CAD, and 20 were diabetic with hypertension) and 30 age- and gender-matched individuals. Lipid and glucose profile were assessed by standard colorimetric assay. Our results revealed that combination of (GT + TT) genotype and T allele significantly increases the risk of hypertension (OR = 3.86 and 4.33), respectively. Subgroup analysis showed significant association between CAD with eNOS (G894T) mutant genotype (P = 0.002) and allele frequency (P < 0.001). Moreover, the mutant homozygous and heterozygous eNOS genotype together were significantly associated with higher TC, LDLc, (P < 0.001), and TG (P = 0.001). Thus, hypercholesterolemia (P < 0.001 and OR = 12.48) increases the risk of hypertension among T carrier. These results indicated that the T carriers significantly increase hypertension risk and complication (CAD), mainly with hypercholesterolemia and in elderly.

Keywords: CVD; Hypertension; eNOS (G894T).

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Alleles*
  • Amino Acid Substitution
  • Female
  • Gene Frequency*
  • Humans
  • Hypertension / enzymology
  • Hypertension / epidemiology
  • Hypertension / genetics*
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Nitric Oxide Synthase Type III / genetics*
  • Polymorphism, Genetic*
  • Risk Factors

Substances

  • NOS3 protein, human
  • Nitric Oxide Synthase Type III